This site is intended for healthcare professionals only
LoginRegister
SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab BiosimilarSEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar
court orderMurder of Amravati Chemist a 'Terror Act', Rules NIA Court, Denies Bail to Accused
Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGIOngoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma...
Cough syrup turns fatal for toddler in JharkhandCDSCO Orders Nationwide Audit of Cough Syrup Makers After Fatal Toxic Syrup Scare
Pill form of Wegovy gets USFDA approval for weight lossCDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol
Dispute over MBBS seats: Delhi HC Quashes Order Compelling Jamia Hamdard University To Grant AffiliationDelhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal...
Himachal cracks down on pharma units, action taken against four facilitiesColdrif fallout: How a Pharma firm skipped India's Drug Watchdog inspections
Punjab Bans Mercury Medical Devices Including Thermometers, BP Monitors, Dental AmalgamColdrif cough syrup banned in Delhi
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo NordiskContaminated Cough syrup tragedy: Sresen Pharma owner remanded in 10-day police custody
Tamil Nadu to Mandate National Formulary Subscription for All Newly Registered PharmacistsCDSCO Panel Seeks More Safety Data from Raptim Research on Lenalidomide Patch
CPS Mumbai Row: Attorney General Assures Supreme Court to Look into the Problem of Affected StudentsSC rejects plea for CBI probe into cough syrup deaths
USFDA concludes inspection at Emcure Pharma Gujarat facility without any observationUSFDA concludes inspection at Emcure Pharma Gujarat facility without any observation
X